Fennec Pharmaceuticals (FENC) Assets (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Assets came in at $70.6 million in Q4 2025, up 56.97% YoY from $44.9 million in Q4 2024, and up 43.22% on a QoQ basis from $49.3 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Assets (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Assets data on file, last reported at $70.6 million in Q4 2025.
- Quarterly Assets rose 56.97% year-over-year to $70.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $70.6 million (up 56.97% YoY) and the FY2025 annual result came in at $70.6 million, up 56.97% from the prior year.
- Assets advanced to $70.6 million in Q4 2025, from $49.3 million in the prior quarter.
- In the past five years, Assets ranged from a high of $70.6 million in Q4 2025 to a low of $15.6 million in Q2 2022.
- A 5-year average of $36.6 million and a median of $28.0 million in 2021 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets slumped 44.63% — and 2024, when it surged 224.95%.
- Tracing FENC's Assets over 5 years: stood at $22.4 million in 2021, then climbed by 20.19% to $26.9 million in 2022, then declined by 0.28% to $26.9 million in 2023, then surged by 67.31% to $44.9 million in 2024, then jumped by 56.97% to $70.6 million in 2025.
- The last three Assets figures came in at $70.6 million (Q4 2025), $49.3 million (Q3 2025), and $44.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 75.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75.75 Mn |
| Dec 31, 2025 | 70.55 Mn |
| Sep 30, 2025 | 49.26 Mn |
| Jun 30, 2025 | 44.88 Mn |
| Mar 31, 2025 | 46.40 Mn |
| Dec 31, 2024 | 44.95 Mn |
| Sep 30, 2024 | 58.92 Mn |
| Jun 30, 2024 | 63.16 Mn |
| Mar 31, 2024 | 69.19 Mn |
| Dec 31, 2023 | 26.86 Mn |
| Sep 30, 2023 | 19.98 Mn |
| Jun 30, 2023 | 19.44 Mn |
| Mar 31, 2023 | 21.82 Mn |
| Dec 31, 2022 | 26.94 Mn |
| Sep 30, 2022 | 30.42 Mn |
| Jun 30, 2022 | 15.57 Mn |
| Mar 31, 2022 | 19.15 Mn |
| Dec 31, 2021 | 22.41 Mn |
| Sep 30, 2021 | 26.01 Mn |
| Jun 30, 2021 | 28.12 Mn |